1-39965291-A-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4BS1_Supporting
The NM_032793.5(MFSD2A):c.434A>G(p.Tyr145Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000093 in 1,613,698 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_032793.5 missense
Scores
Clinical Significance
Conservation
Publications
- microcephaly 15, primary, autosomal recessiveInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive primary microcephalyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_032793.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MFSD2A | NM_032793.5 | MANE Select | c.434A>G | p.Tyr145Cys | missense | Exon 4 of 14 | NP_116182.2 | ||
| MFSD2A | NM_001287808.2 | c.-35A>G | 5_prime_UTR_premature_start_codon_gain | Exon 2 of 12 | NP_001274737.1 | ||||
| MFSD2A | NM_001136493.3 | c.473A>G | p.Tyr158Cys | missense | Exon 4 of 14 | NP_001129965.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MFSD2A | ENST00000372811.10 | TSL:1 MANE Select | c.434A>G | p.Tyr145Cys | missense | Exon 4 of 14 | ENSP00000361898.6 | ||
| MFSD2A | ENST00000483824.5 | TSL:1 | n.569A>G | non_coding_transcript_exon | Exon 4 of 12 | ||||
| MFSD2A | ENST00000420632.6 | TSL:2 | c.-35A>G | 5_prime_UTR_premature_start_codon_gain | Exon 2 of 12 | ENSP00000391261.2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 151822Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000795 AC: 20AN: 251470 AF XY: 0.0000957 show subpopulations
GnomAD4 exome AF: 0.0000917 AC: 134AN: 1461876Hom.: 0 Cov.: 32 AF XY: 0.0000866 AC XY: 63AN XY: 727240 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000105 AC: 16AN: 151822Hom.: 0 Cov.: 32 AF XY: 0.0000809 AC XY: 6AN XY: 74130 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Inborn genetic diseases Uncertain:1
The c.473A>G (p.Y158C) alteration is located in exon 4 (coding exon 4) of the MFSD2A gene. This alteration results from a A to G substitution at nucleotide position 473, causing the tyrosine (Y) at amino acid position 158 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at